![](https://d1htlas1ystcvb.cloudfront.net/securities/2421/cbecc49c38cf2b89832a3afe1fc30d4ed41bdb94.png)
ARK Genomic Revolution
(ARCG)
£3.39
Previous business day’s close price
‑£0.13 (‑3.6%)
max available period
£3.40
£4.05
19 Apr 24
01 Jul 24
Details
This ETF is actively managed and invests primarily in global equity securities of companies involved in the genomic revolution. These are companies that are substantially focused on or benefit from extending and enhancing the quality of human and other life. The investment manager uses both ‘top down’ and ‘bottom up’ approaches to select companies. This ETF reinvests income.
Ticker: ARCG
ISIN: IE000O5M6XO1
Full Name: ARK Genomic Revolution UCITS ETF’
Ticker: ARCG
ISIN: IE000O5M6XO1
Full Name: ARK Genomic Revolution UCITS ETF’
Key information
ETF Breakdown
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7625/02561de88650776fc892cbf2bb407f281a80785e.png)
Twist Bioscience Corp
9.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10845/a3135de14a1d8790d363135b4e9a9bc5243ab16c.png)
CRISPR Therapeutics AG
7.9%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/15295/d75ccf0784a027bc9760b85a95d72471839ef257.png)
Recursion Pharmaceuticals Inc
6.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7731/b803f485d95574e32f3fd5479803917dbb40f743.png)
Caredx Inc
6.0%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7947/596d77d504e4a31761abd898b20e1730b43d72b5.png)
Intellia Therapeutics Inc
4.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7431/3447b3d68f658afb4a771aad69cc47e8585a9995.png)
Ionis Pharmaceuticals Inc
4.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/9895/5207b0d978a33f15796b568918bc6f1a685062ac.png)
Nurix Therapeutics Inc
3.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/20195/e1576d47a55f7854005623d108fd6fa5fb63c9ea.png)
Arcturus Therapeutics Holdings Inc
3.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7781/81d528a6daf257a3ca02b92d3aebe8f4197f9a02.png)
Beam Therapeutics Inc
3.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1787/c5d37b6bb83437f6bc61b7c1a3235ccab041adba.png)
Moderna Inc
3.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7935/4aba4bdc3c749dc25b5cf5d025b045164a4c6faf.png)
Schrodinger Inc
3.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7737/a9d98770bb6a542d470d9363991eea2871688f48.png)
Veracyte Inc
3.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2333/0d449023c7976baf1479511dbea3d03150e96a45.png)
10x Genomics Inc
2.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/15905/5f4966d0947953188c9e177c920fda4a8bc1029a.png)
Adaptive Biotechnologies Corp
2.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1649/fdca1ade0333b26298bd832c6770ccd24ce81586.png)
Vertex Pharmaceuticals, Inc.
2.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/9589/a8de83b61ece6cf34fc366fd48f33ddcc562ba6d.png)
Accolade Inc
2.5%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2109/2bd9b2dc8ad3cbffb0d446f69de640b81ae87044.png)
Veeva Systems Inc
2.3%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2211/879e744661f8305677cd86e3cfd151db3040453b.png)
Incyte Corp.
1.9%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/10083/9aff623d0dd8845c4ed1485e2c28858bd8ea5291.png)
Standard BioTools Inc
1.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1889/85b35c58409adc9b67ca0b5fcca701c198b4817c.png)
Teladoc Health Inc
1.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1535/95ad82c2f8ad4210ef821ffcb45e9713b51987d3.png)
AMGEN Inc.
1.8%
Ginkgo Bioworks Holdings Inc
1.6%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/15377/a542aece57886f3cb06daa3b313165dc5cf5647a.png)
908 Devices Inc
1.6%
Pacific Biosciences of California Inc
1.4%
Prime Medicine Ord Shs
1.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/1755/8afa23c6c0575dbffe33cafdad1142d00be97f32.png)
Regeneron Pharmaceuticals, Inc.
1.4%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/2081/732aee1c5d9caf87a93e4a7ea49143aa064e9155.png)
Exact Sciences Corp.
1.4%
Quantum‑Si Incorporated
1.2%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/7455/7dcbd8aa600283596db78caaa7d727326ec4f267.png)
Natera Inc
1.2%
Tempus Ai
1.1%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/15703/c935bdb4279b4fc04ee3ce986d02eb4a20adc8c0.png)
Guardant Health Inc
1.0%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/9021/3c68686d60dcbcba7cc2fb64671761687581be72.png)
Cerus Corp.
1.0%
Absci Corp
1.0%
Compass Pathways Plc
1.0%
Verve Therapeutics Inc
1.0%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/20031/2a2816fc31d9789a551cb8ab3b44b4448a9a7bb0.png)
Butterfly Network Inc
0.8%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/20297/4e3b75b648d88efed80d26769168b0eb87c1c58c.png)
Repare Therapeutics Inc
0.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/19671/53fb66740428292133073cea13934660539ffa97.png)
UiPath Inc
0.7%
![](https://d1htlas1ystcvb.cloudfront.net/organisations/9339/299c29fa23fa25184ec32ca2cd8e758df3056e65.png)
Personalis Inc
0.6%
Senti Biosciences
< 0.1%
Others
< 0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
83.9%
Europe ex‑UK
7.9%
Rest of the World
8.2%
Technology
37.5%
Healthcare
31.0%
Industrial
13.3%
Financial
2.5%
Sector ‐ Other
15.7%
Why InvestEngine
Unbeatable value
From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it
Here's how we're able to do it
Choice of 660+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.